Modulating release of ranibizumab and aflibercept from thiolated chitosan-based hydrogels for potential treatment of ocular neovascularization
Background: This paper describes the synthesis of thiolated chitosan-based hydrogels with varying degrees of crosslinking that has been utilized to modulate release kinetics of two clinically relevant FDA-approved anti-VEGF protein drugs, ranibizumab and aflibercept. These hydrogels have been fabric...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
其他作者: | |
格式: | Article |
語言: | English |
出版: |
2017
|
主題: | |
在線閱讀: | https://hdl.handle.net/10356/84063 http://hdl.handle.net/10220/42956 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|